COVID-19 Updates

Omicron subvariant BA.5 more virulent: Study

Scientists have used engineered mice to compare SARS-COV-2 Omicron subvariants and found that the BA.5 strain was more virulent likely due to its ability to rapidly replicate early during infection.

The research, published in the journal Science Advances, addresses a challenge to studying and understanding rapidly evolving variants of concern due to a lack of animal models for running tests that could help explain why variants and subvariants each behave differently in people.

The genetically modified mice, called K18-hACE2, used in the research express a human receptor that allowed SARS-COV-2 to enter otherwise inaccessible mouse cells.

“One of the things we found is that the strain that causes more pathology, BA.5, replicates much faster early on during infection,” said Avery August, a professor in the College of Veterinary Medicine (CVM) at Cornell University in the US.

“By doing that, the virus generates a really strong immune response, which then leads to increased pathology and symptoms compared to subvariants that don’t replicate as fast,” August said.

Prior to this study, there were no small animal models to study the new SARS-CoV-2 Omicron variants of concern, because no animals got sick with other variants, the researchers said.

“Our study allows us to use relatively older K18-hACE2 mice as a disease model to understand how the virus becomes pathogenic, and to test whether and how vaccines and antivirals work for the new Omicron sub-variants,” said Hector Aguilar-Carreno, a professor of virology at CVM.

 Early Omicron BA.1 and BA.2 subvariants also replicated and spread in the K-18 mice, but they caused minimal illness and death.

Medlarge

Recent Posts

ICMR starts first in-human clinical trials for Zika vaccine

The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…

2 months ago

Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…

2 months ago

NITI Ayog suggests separate legislation, fund for future pandemic

A report by an expert group set up by NITI Aayog report titled ‘Future Pandemic…

2 months ago

Health ministry seeks action-taken report from hospitals on Kolkata incident

The union health ministry has sought an action taken report from State governments and Union…

2 months ago

Jupiter hospital drives future of Healthcare Management with JASPER 2024

Jupiter Hospital, a leading tertiary care provider in Pune, recently hosted the Jupiter Administration Symposium…

2 months ago

Mock drill held on pandemic preparedness under National One Health Mission

Under the aegis of National One Health Mission (NOHM), a comprehensive national mock drill, "Vishanu…

2 months ago